ClinicalTrials.gg
RecruitingNCT07885124Updated Oct 21, 2026

Driving Pressure-Guided Individualized PEEP Versus Standard PEEP: Effects on Postoperative Pulmonary Complications in Upper Abdominal Digestive Surgery

An interventional study of Driving Pressure-Guided Individualized PEEP and Standard PEEP in Postoperative Pulmonary Complications and Mechanical Ventilation, sponsored by Hopital Charles Nicolle. Recruiting at 1 site in Tunisia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Hopital Charles Nicolle · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled May 2026, registered Sep 2026).
  • Started May 2026; still recruiting 5 months later.
Updated Oct 21, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
210
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized clinical trial compares two methods of setting positive end-expiratory pressure (PEEP) during general anesthesia in adults undergoing upper abdominal digestive surgery who are at moderate or high risk of postoperative pulmonary complications.

All participants will receive lung-protective mechanical ventilation. Participants will be randomly assigned to one of two groups. In the individualized PEEP group, PEEP will be adjusted to achieve the lowest driving pressure following a lung recruitment maneuver. In the standard PEEP group, PEEP will be fixed at 5 cmH2O.

The main question is whether driving pressure-guided individualized PEEP reduces the proportion of participants who develop one or more postoperative pulmonary complications during the first 7 days after surgery compared with standard PEEP.

Read the detailed description

Postoperative pulmonary complications are common after upper abdominal surgery and can increase postoperative morbidity and length of hospital stay. Although positive end-expiratory pressure may help prevent alveolar collapse during general anesthesia, a fixed PEEP level may be insufficient for some patients and excessive for others.

Driving pressure is calculated as plateau pressure minus PEEP and reflects the pressure required to deliver the tidal volume to the respiratory system. Individualizing PEEP according to the lowest driving pressure may improve respiratory-system compliance while limiting both alveolar collapse and overdistension.

In this prospective, randomized, controlled, parallel-group trial, eligible participants will be randomly allocated in a 1:1 ratio to either driving pressure-guided individualized PEEP or standard PEEP. In the individualized PEEP group, a lung recruitment maneuver will be followed by a decremental PEEP trial. The PEEP level associated with the lowest driving pressure will be selected, provided that adequate oxygenation and hemodynamic stability are maintained. In the standard PEEP group, PEEP will be maintained at 5 cmH2O. All other aspects of lung-protective ventilation and perioperative care will be standardized between the groups.

Participants and the independent postoperative outcome assessor will remain unaware of treatment allocation. Postoperative pulmonary complications will be assessed from the day of surgery through postoperative day 7.

02

Conditions studied

  • Postoperative Pulmonary Complications
  • Mechanical Ventilation

Keywords

  • Driving Pressure
  • Individualized PEEP
  • Positive End-Expiratory Pressure
  • PEEP Titration
  • Lung Recruitment Maneuver
  • Lung-Protective Ventilation
  • Upper Abdominal Surgery
  • ARISCAT Score
  • Perioperative Mechanical Ventilation
03

In context

Lead sponsor

Hopital Charles Nicolle is the lead sponsor of 11 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • Scheduled for supra-mesocolic upper abdominal digestive surgery.
  • (ASA) physical status I, II, or stable III.
  • Moderate or high risk of postoperative pulmonary complications, defined by an Assess Respiratory Risk in Surgical Patients in Catalonia (ARISCAT) score of 26 or higher.
  • Provision of written .

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate or inability to provide written .
  • Pregnancy.
  • greater than III.
  • History of acute respiratory distress syndrome.
  • Pulmonary hypertension.
  • Bronchopleural fistula.
  • with severe emphysema.
  • Pre-existing cardiac arrhythmia.
  • Decompensated heart failure.
  • Known condition associated with increased intracranial pressure.
  • Intra-abdominal hypertension.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
210 participants (estimated)

Study arms

  • Experimental
    Driving Pressure-Guided Individualized PEEP

    Participants receive a lung recruitment maneuver followed by a decremental PEEP trial. The PEEP level associated with the lowest driving pressure is selected, provided that adequate oxygenation and hemodynamic stability are maintained.

    Procedure: Driving Pressure-Guided Individualized PEEP

  • Active comparator
    Standard PEEP

    Participants receive lung-protective mechanical ventilation with a fixed PEEP of 5 cmH2O throughout the intraoperative ventilation period.

    Procedure: Standard PEEP

Interventions

  • ProcedureDriving Pressure-Guided Individualized PEEP

    Participants assigned to this experimental arm receive a lung recruitment maneuver followed by a decremental PEEP trial. Driving pressure is calculated as plateau pressure minus PEEP at each tested level. The PEEP associated with the lowest driving pressure is selected and maintained during surgery, provided that adequate oxygenation and hemodynamic stability are preserved.

  • ProcedureStandard PEEP

    Participants receive lung-protective mechanical ventilation with PEEP fixed at 5 cmH2O throughout the intraoperative ventilation period. The other components of perioperative ventilation and care are standardized between the two groups.

06

What researchers measure

Primary outcomes

  1. postoperative pulmonary complications

    Incidence of postoperative pulmonary complications occurring within the first 7 postoperative days, according to the study-defined criteria.

    Time frame: From the end of surgery through postoperative day 7 (up to 7 days)

Secondary outcomes

  1. Length of hospital stay

    Length of hospital stay will be calculated as the number of days from the date of surgery to the date of hospital discharge.

    Time frame: From the day of surgery through hospital discharge, assessed up to 30 days after surgery.

  2. Postoperative Intensive Care Unit Admission

    Number and percentage of participants requiring admission to an intensive care unit after surgery.

    Time frame: From the end of surgery through hospital discharge, assessed up to 30 days after surgery.

  3. Intensive Care Unit Length of Stay

    Among participants admitted to the intensive care unit, length of stay measured in calendar days from intensive care unit admission to intensive care unit discharge.

    Time frame: At intensive care unit discharge, assessed up to 30 days after surgery.

  4. Intraoperative Tidal Volume

    Tidal volume delivered during mechanical ventilation, expressed in mL/kg of ideal body weight and recorded at predefined intraoperative time points.

    Time frame: 10 minutes after tracheal intubation; 1, 2, and 3 hours after intubation; and at the end of surgery.

  5. Median Intraoperative Positive End-Expiratory Pressure

    Median positive end-expiratory pressure (PEEP) applied during intraoperative mechanical ventilation, expressed in cmH2O and calculated from values recorded at the predefined intraoperative assessment points.

    Time frame: 10 minutes after tracheal intubation; 1, 2, and 3 hours after intubation; and at the end of surgery.

  6. Intraoperative Peak Airway Pressure

    Peak airway pressure measured during intraoperative mechanical ventilation, expressed in cmH2O.

    Time frame: 10 minutes after tracheal intubation; 1, 2, and 3 hours after intubation; and at the end of surgery.

  7. Intraoperative Plateau Pressure

    Plateau pressure measured during an end-inspiratory occlusion lasting 2 to 3 seconds, expressed in cmH2O.

    Time frame: From initiation of mechanical ventilation after tracheal intubation through the end of surgery

  8. Intraoperative Static Respiratory System Compliance

    Static respiratory system compliance calculated as tidal volume divided by the difference between plateau pressure and positive end-expiratory pressure, expressed in mL/cmH2O.

    Time frame: From initiation of mechanical ventilation after tracheal intubation through the end of surgery

  9. Intraoperative Dynamic Respiratory System Compliance

    Dynamic respiratory system compliance calculated as tidal volume divided by the difference between peak airway pressure and positive end-expiratory pressure, expressed in mL/cmH2O.

    Time frame: From initiation of mechanical ventilation after tracheal intubation through the end of surgery

  10. Intraoperative Systolic Arterial Pressure

    Systolic arterial pressure measured every 5 minutes during surgery and expressed in mmHg.

    Time frame: From anesthetic induction through the end of surgery

  11. Intraoperative Diastolic Arterial Pressure

    Diastolic arterial pressure measured every 5 minutes during surgery and expressed in mmHg.

    Time frame: From anesthetic induction through the end of surgery

  12. Intraoperative Mean Arterial Pressure

    Mean arterial pressure measured every 5 minutes during surgery and expressed in mmHg.

    Time frame: From anesthetic induction through the end of surgery

  13. Intraoperative Heart Rate

    Heart rate measured continuously and recorded every 5 minutes during surgery, expressed in beats per minute.

    Time frame: From anesthetic induction through the end of surgery

  14. Postoperative Intensive Care Unit Admission

    Number and percentage of participants requiring admission to an intensive care unit after surgery.

    Time frame: From the end of surgery until hospital discharge, assessed up to 30 days postoperatively.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • PROVE Network Investigators for the Clinical Trial Network of the European Society of Anaesthesiology; Hemmes SN, Gama de Abreu M, Pelosi P, Schultz MJ. High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial. Lancet. 2014 Aug 9;384(9942):495-503. doi: 10.1016/S0140-6736(14)60416-5. Epub 2014 Jun 2. PubMed 24894577 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07885124
Lead sponsor
Hopital Charles Nicolle
Responsible party
jebri alia (Head of the Department of Anesthesiology and Intensive Care, Hopital Charles Nicolle) — Principal investigator
First posted
Oct 21, 2026
Start date
May 22, 2026
Primary completion
Jun 22, 2027 (estimated)
Completion
Jun 22, 2027 (estimated)
Last update
Oct 21, 2026

Study contacts

Hallouma Ben Fredj, MD
Contact
hallouma.benfredj@fmt.utm.tn
25207433

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion